Cell-Free Protein Synthesis Platforms Derived From Clostridia Extracts
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- LANZATECH, INC., Skokie, Illinois has been assigned a patent (No. US 12157908 B2, initially filed Feb. 25, 2020) developed by four inventors Michael Christopher Jewett, Evanston, Illinois; Antje Kruger-Gericke, Evanston, Illinois; Alexander Paul Mueller, Skokie, Illinois; and Michael Koepke, Chicago, Illinois, for "Cell-free protein synthesis platforms derived from clostridia extracts." . . .